Inovio Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)3holders
$13.88avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Inovio Pharmaceuticals Inc. in their 13F filings. The largest holders were Prime Capital Investment Advisors, LLC ($141K), IFP Advisors, Inc ($2K) and Sachetta, LLC ($2).
- Company
- Inovio Pharmaceuticals Inc.
- CUSIP
- 45773H201
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2 |
| Exits | 49 | $3.0M |
Ownership 3 holders
| Prime Capital Investment Advisors, LLC | 0.00% | Reduce -92.2% | 10,172 | $141K |
| IFP Advisors, Inc | 0.00% | Reduce -76.7% | 175 | $2K |
| Sachetta, LLC | 0.00% | New | 3 | $2 |
"% of holder's portfolio" is INOVIO PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Inovio Pharmaceuticals Inc. the manager owns.